INCB161734 Clinical Trials

2 actively recruiting trials across 2 locations

No change since May 2026

Pipeline

Phase 1: 1Phase 3: 1

Top Sponsors

Incyte Corporation2

Indications

Solid Tumors2
Cancer2
Lung Cancer1

Birmingham, Alabama1 trial

A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

Investigative Site US058

Phase 3

Phoenix, Arizona1 trial

A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

Mayo Clinic Hospital

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.